CareCloud Inc (CCLDO) Aktienanalyse

Unternehmensübersicht

CareCloud, Inc. operates within the healthcare sector as a specialized provider of health information services, delivering technology-enabled business solutions and Software-as-a-Service offerings to healthcare providers and hospitals primarily located in the United States. The company functions through its Healthcare IT and Medical Practice Management segments, focusing on digitizing and optimizing clinical workflows for medical institutions. With a workforce of 3,650 employees, the organization demonstrates significant operational scale within the niche of medical practice management and IT infrastructure. While specific market capitalization data is currently unavailable, the company's reported trailing twelve-month revenue of $120.50 million serves as a key indicator of its market presence and revenue generation capacity. These financial figures, combined with the substantial employee base, suggest that CareCloud, Inc. has established itself as a mature entity capable of sustaining operations and delivering value-added services across the U.S. healthcare landscape, distinguishing it from smaller, early-stage technology firms.

Finanzielle Gesundheit

CareCloud, Inc. reported a trailing twelve-month revenue of $120.50 million, generating net income of $3.89 million and an EBITDA of $16.39 million during the reporting period. The disparity between the total revenue figure and the net income results reveals a cost structure where operational expenses, including cost of goods sold and operating overheads, consumed approximately 96.7% of the gross revenue before reaching the bottom line. The company generated free cash flow of $18.23 million, a metric that indicates strong financial flexibility, suggesting that the business model effectively converts revenue into liquid assets available for reinvestment or debt servicing without relying heavily on external financing. Profitability analysis shows a gross margin of 46.5%, an operating margin of 9.1%, and a profit margin of 9.0%; these figures indicate that while the company maintains pricing power or cost efficiencies in its direct costs, significant operating leverage is required to maximize returns on sales. The balance sheet presents a conservative leverage profile with cash reserves of $3.12 million compared to total debt of $4.28 million, supported by a debt-to-equity ratio of 7.20 which reflects a high reliance on equity financing relative to debt obligations. Liquidity management appears robust with a current ratio of 1.05, indicating that the company holds sufficient current assets to cover its short-term liabilities without immediate distress. Return on equity stands at 19.8% while return on assets is 9.0%, metrics that collectively reveal management's effectiveness in deploying capital to generate shareholder value relative to the equity invested and the total asset base utilized.

Bewertungsanalyse

Trailing and forward P/E ratios are both listed as unavailable (N/A), which implies that the market currently lacks sufficient earnings data to calculate a standard price-to-earnings multiple, often seen in companies with volatile or negative earnings histories that fluctuate significantly year-over-year. The price-to-book ratio is reported at 18.71, a figure that indicates a substantial market premium over the company's book value, suggesting that investors are pricing in significant intangible assets, future growth potential, or brand value that are not captured on the traditional accounting balance sheet. Alternative valuation metrics provide further context, with an enterprise value-to-EBITDA of 68.11 and an unavailable price-to-sales ratio; the high EV/EBITDA multiple suggests that the market values the company's earnings power at a premium relative to its debt-adjusted valuation benchmarks. Regarding trading range, the 52-week high was $26.75 and the low was $17.30; without a specific current price point provided in the available facts to calculate a precise percentage deviation, the stock has demonstrated significant volatility within this $9.45 range over the past year. The beta value is 1.83, which indicates that the stock's price volatility is nearly double that of the broader market, meaning it experiences amplified price swings during periods of market stress or rally compared to large-cap peers.

Growth & Income

CareCloud, Inc. achieved a year-over-year revenue growth rate of 21.9%, while earnings growth is listed as unavailable (N/A); the absence of reported earnings growth data prevents a direct comparison of growth rates, though the strong revenue expansion suggests the top line is outpacing historical earnings performance in recent periods. The company currently offers a dividend yield of 8.3%, which is notably high, but the payout ratio is unavailable, making it impossible to determine the sustainability of this yield based on current earnings without the specific payout percentage. Given the unavailable payout ratio and the context of high revenue growth, the company appears to balance dividend distribution with the need to fund its high-growth trajectory and operational scaling efforts. The overall growth and income profile is characterized by aggressive top-line expansion coupled with a significant current yield, presenting a unique hybrid characteristic for a technology-enabled healthcare services firm that must simultaneously manage rapid scaling and shareholder returns.